Status:
COMPLETED
Early Identification and Action in CKD
Lead Sponsor:
Geisinger Clinic
Conditions:
Chronic Kidney Disease
Hypertension
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Chronic kidney disease (CKD) is highly prevalent and associated with significantly increased risk of cardiovascular morbidity and end-stage renal disease. Evidence from randomized clinical trials sugg...
Eligibility Criteria
Inclusion
- 18 years of age or older
- eGFRCR value between 45-59 ml/min/1.73m2 in the prior 12 months
- scheduled laboratory appointment for serum creatinine testing within the next 30 days
- average systolic or diastolic blood pressure reading of at least 150 or 85 mm Hg, respectively, during the prior 12 months.
Exclusion
- fewer than 2 blood pressure readings in the prior 12 months,
- pregnancy
- current hospitalization
- life expectancy less than 6 months as determined by the study investigators
Key Trial Info
Start Date :
September 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2016
Estimated Enrollment :
47 Patients enrolled
Trial Details
Trial ID
NCT02208674
Start Date
September 1 2014
End Date
March 1 2016
Last Update
November 15 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Geisinger Health System
Danville, Pennsylvania, United States, 17822